General characteristics of patients with isolation of Mycobacterium simiae
| Sex | |
| Male | 5/7 |
| Female | 2/7 |
| Disposition | |
| CF | 3/7 |
| Non-CF | 4/7 |
| HIV | 1/7 |
| Malignoma | 2/7 |
| SLD | 2/7 |
| Clinical manifestation | |
| Isolated pulmonary | 6/7 |
| Isolated extrapulmonary | 0/7 |
| Disseminated | 1/7 |
| ATS criteria | 2/6 |
| Pulmonary symptoms and radiology | 2/6 |
| Exclusion other diagnosis | 2/6 |
| Two culture-positive sputa | 3/6 |
| Positive culture in BALF | 3/6 |
| Biopsy and culture | 1/6 |
| NTM therapy | 3/7 |
| Macrolide | 3/3 |
| Ethambutol | 1/3 |
| Rifamycin | 1/3 |
| Fluoroquinolone | 3/3 |
| Clofazimin | 1/3 |
| Cotrimoxazol | 2/3 |
| Linezolid | 1/3 |
| Deceased | 0/7 |
| Culture conversion | 5/7 |
| Other NTM isolated during the observation period | |
| M. abscessus | 2/7 |
| M. chimaera | 1/7 |
| M. intracellulare | 1/7 |
| M. chelonae | 1/7 |
CF: cystic fibrosis; SLD: structural lung disease; BALF: bronchoalveolar lavage fluid; NTM: non-tuberculous mycobacterium.